Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Y H Chi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Fundamental & Clinical Pharmacology|November 30, 2005
Some issues with composite endpoints in clinical trialsGeorge Y H Chi
Statistics in Medicine|February 3, 2007
A method for testing a prespecified subgroup in clinical trialsYang Song, George Y H Chi
Journal of Biopharmaceutical Statistics|November 9, 2010
Understanding the FDA guidance on adaptive designs: historical, legal, and statistical perspectivesQing Liu, George Y H Chi
Journal of Biopharmaceutical Statistics|June 23, 2004
Hypotheses and type I error in active-control noninferiority trialsGang Chen, Yong-Cheng Wang, George Y H Chi
Journal of Biopharmaceutical Statistics|April 6, 2006
A ratio test in active control non-inferiority trials with a time-to-event endpointYong-Cheng Wang, Gang Chen, George Y H Chi
Journal of Biopharmaceutical Statistics|March 19, 2004
Evaluation of health-related quality-of-life measures in oncology drug product applications: issues and concernsRajeshwari Sridhara, Gang Chen, George Y H Chi, et al.
Contemporary Clinical Trials Communications|May 9, 2018
On clinical trials with a high placebo response rateGeorge Y H Chi, Yihan Li, Yanning Liu, et al.
Statistics in Medicine|January 10, 2003
Design and analysis of non-inferiority mortality trials in oncologyMark Rothmann, Ning Li, Gang Chen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Fundamental & Clinical Pharmacology|November 30, 2005
Some issues with composite endpoints in clinical trialsGeorge Y H Chi
Statistics in Medicine|February 3, 2007
A method for testing a prespecified subgroup in clinical trialsYang Song, George Y H Chi
Journal of Biopharmaceutical Statistics|November 9, 2010
Understanding the FDA guidance on adaptive designs: historical, legal, and statistical perspectivesQing Liu, George Y H Chi
Journal of Biopharmaceutical Statistics|June 23, 2004
Hypotheses and type I error in active-control noninferiority trialsGang Chen, Yong-Cheng Wang, George Y H Chi
Journal of Biopharmaceutical Statistics|April 6, 2006
A ratio test in active control non-inferiority trials with a time-to-event endpointYong-Cheng Wang, Gang Chen, George Y H Chi
Journal of Biopharmaceutical Statistics|March 19, 2004
Evaluation of health-related quality-of-life measures in oncology drug product applications: issues and concernsRajeshwari Sridhara, Gang Chen, George Y H Chi, et al.
Contemporary Clinical Trials Communications|May 9, 2018
On clinical trials with a high placebo response rateGeorge Y H Chi, Yihan Li, Yanning Liu, et al.
Statistics in Medicine|January 10, 2003
Design and analysis of non-inferiority mortality trials in oncologyMark Rothmann, Ning Li, Gang Chen, et al.
Pageof 1